USPTO 2015–2025 USPTO PatentsView US Corporation

Kyocera Medical Technologies, Inc.

USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Kyocera ranks #41,321 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.

#41,321
of 49,997 US assignees by volume
Top 34%
by Innovation Score (41.0/100)
9.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R41321 · US Corporation #41,321 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 6 grants
  • LOWER-Q #41,321/49,997
  • PHOTO-FINISH Kustom Cycles
  • CPC-NARROW A61F · 6 areas
  • INNOV-PAR 41.0/100
  • CLAIMS-PAR 9.3 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2020–2025 · 6y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Kustom Cycles, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Kyocera’s 41.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Kyocera

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Kyocera's Innovation Score is 41.0/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Kyocera?

Each dot is one of Kyocera’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Kyocera’s own 9.3 claims/patent is at or below the 13.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Kyocera vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 5.96.06.066.06.06.1 0510152025 Granted patents (volume) Avg claims / patent Kustom Cycles, Inc. - 6, 16.67Kustom CyclesKutta Technologies, Inc. - 6, 20.17KuttaKvadrat Soft Cells A/S - 6, 18Kvadrat Soft Cell…Kverneland Group Les Landes Génusson S.A.S. - 6, 20.5Kverneland Group…L.A. Gem and Jewelry Design, Inc. - 6, 1L A Gem and Jewel…LA Casa Vhernier S.p.A. - 6, 1LA Casa Vhernier…LA Montre Hermes S.A. - 6, 5.17LA Montre HermesLaboratori Baldacci S.P.A. - 6, 13.33Laboratori Baldac…Kyocera Medical Technologies, Inc. - 6, 9.33Kyocera Medical
Kyocera vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Kyocera's grants concentrate

Kyocera Medical Technologies, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 66.7% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2020. By volume, Kyocera sits between Kustom Cycles, Inc. and Laboratori Baldacci S.P.A..

Kyocera's three-year grant acceleration

Kyocera Medical Technologies, Inc. shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Kyocera's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Kyocera holds 6 patents at rank #41,297, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Kyocera

By rank, the assignees closest to #41,297 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Kyocera's primary technology class.

Kyocera's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 20202022202320242025 1
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Kyocera Medical Technologies, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 16.7%
2022 1 16.7%
2023 1 16.7%
2024 2 33.3%
2025partial year 1 16.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Kyocera Medical Technologies, Inc.'s patent record in context - here's where to go next.

  • Kyocera Medical Technologies, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 66.7% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #41,321 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Kyocera Medical Technologies, Inc. against Kustom Cycles, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 41.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.